šØ Abstract
COSCIENS Biopharma Inc. reported a $3.7 million loss in the first quarter of 2025. On a per-share basis, the loss amounts to $1.16. The Toronto-based drug developer reported revenue of $1.5 million for the same period.
Courtesy: wtop.com
Suggested
20 estados demandan al Gobierno de Trump por usar fondos federales para aplicar la ley migratoria -
Interim US Attorney for DC criticizes local leaders on his last day in office -
Texas prosecutor sues to compel Border Patrol testimony in trial of Uvalde police officer -
Prince Georgeās Co. Chair rescinds $2 million in grants, sends county nonprofits scrambling -
Private equity firm launches $10M investment accelerator for family-owned DC-area companies -
āDoes affect businessā: Bethesda businesses get financial relief to offset losses from Purple Line construction -
Pluri: Fiscal Q3 Earnings Snapshot -
QuickLogic: Q1 Earnings Snapshot -
A full list of the players, coaches and owners permanently banned by Major League Baseball -